Your browser doesn't support javascript.
loading
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
Hasanov, Merve; Rioth, Matthew J; Kendra, Kari; Hernandez-Aya, Leonel; Joseph, Richard W; Williamson, Stephen; Chandra, Sunandana; Shirai, Keisuke; Turner, Christopher D; Lewis, Karl; Crowley, Elizabeth; Moscow, Jeffrey; Carter, Brett; Patel, Sapna.
Affiliation
  • Hasanov M; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Rioth MJ; Division of Medical Oncology and Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Kendra K; Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
  • Hernandez-Aya L; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA..
  • Joseph RW; Department of Hematology and Oncology, Mayo Clinic Hospital, Florida, Jacksonville, FL 32224, USA.
  • Williamson S; Division of Medical Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Chandra S; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Shirai K; Division of Hematology and Oncology, Department of Medicine, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766, USA.
  • Turner CD; Blueprint Medicines, Clinical Development, Cambridge, MA 02139, USA.
  • Lewis K; Division of Medical Oncology and Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Crowley E; Celldex Therapeutics, Inc., Hampton, NJ 08827, USA.
  • Moscow J; Cancer Therapy Evaluation Program National Institute of Health (CTEP), Bethesda, MD 20892, USA.
  • Carter B; Department of Thoracic Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Patel S; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancers (Basel) ; 12(8)2020 Aug 13.
Article in En | MEDLINE | ID: mdl-32823698
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Estados Unidos